BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

9 hedge funds and large institutions have $940K invested in Virtus LifeSci Biotech Clinical Trials ETF in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

86% less call options, than puts

Call options by funds: $17K | Put options by funds: $123K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17K
Puts
$123K
Net Calls
Net Calls Change

Top Buyers

1 +$371K
2 +$175K
3 +$14.1K

Top Sellers

1 -$1.05M
2 -$53.5K
3 -$19.7K
4
Osaic Holdings
Osaic Holdings
Arizona
-$10.7K
5
UBS Group
UBS Group
Switzerland
-$4.02K